Skip to content
10-Q

Quarterly Report

NEOGENOMICS INC NEO

0001077183-25-000076

← back to feed
Filed
Apr 29, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 25, 2025 128.69M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $346.19M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $367.01M
Current Liabilities Q1 2025 · Mar 31, 2025 $279.7M
Current Liabilities Q1 2025 · Dec 31, 2024 $301.24M
Total Liabilities Q1 2025 · Mar 31, 2025 $713.16M
Total Liabilities Q1 2025 · Dec 31, 2024 $735.7M
Current Assets Q1 2025 · Mar 31, 2025 $573.93M
Current Assets Q1 2025 · Dec 31, 2024 $596.02M
Total Assets Q1 2025 · Mar 31, 2025 $1.6B
Total Assets Q1 2025 · Dec 31, 2024 $1.64B
Shares Diluted Q1 2025 · Mar 31, 2024 126.11M sh
Capex Q1 2025 · Mar 31, 2024 $5.59M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$25.92M
Stockholders Equity Q1 2025 · Mar 31, 2024 $923.41M
Stockholders Equity Q1 2025 · Dec 31, 2023 $941.54M
Sga Expense Q1 2025 · Mar 31, 2024 $65.8M
Rd Expense Q1 2025 · Mar 31, 2024 $7.62M
Net Income Q1 2025 · Mar 31, 2024 −$27.06M
Operating Income Q1 2025 · Mar 31, 2024 −$30.57M
Gross Profit Q1 2025 · Mar 31, 2024 $65.47M